Substance Use Treatment

Meet Our Experts: Substance Use Counselors

APM was the first agency in Philadelphia to provide treatment for substance use disorder designed for the Latino community. We offer structured, evidence-based intensive, and regular outpatient services to adolescents and adults with substance use and related disorders.

APM’s staff culturally sensitive engage in creating a personalized treatment plan for each participant that is focused on recovery management. Our services include extensive health and social service programs proven to reduce factors that trigger high-risk situations for people with substance use disorder.

Participants must:

Complete intake process, including urine screening and laboratories.
Be examined by our therapist and physicians
Have medical insurance, private pay and/or proof of identity

How does it work?

Individual therapy sessions with a trained Substance use Counselor
Group sessions
Relapse prevention
Behavioral Health Education
Monthly Medication Management appointments with a physician

Key Offerings

Medication for Assisted Treatment (MAT)

Buprenorphine (Cizdol, Suboxone, Subutex, Zubsolv, Bunavail, Sublocade), in combination with counseling and behavioral therapies, provides a personalized approach to the treatment of opioid use disorder. If taken as prescribed, buprenorphine is safe and effective (SAMHSA, 2019).

Naltrexone (ReVia, Depade, Vivitrol), is prescribed for both alcohol and opioid use disorder. The medication blocks the euphoric and sedative effects of these substances by binding and blocking opioid receptors.

Works together with counseling and therapy, allowing people with alcohol use and related disorders to reduce their drinking behaviors and avoid relapses. Naltrexone is not addictive, nor does it react adversely with alcohol(SAMHSA, 2019).

Other medications that are FDA approved as MAT for alcohol use disorder are available for participants. these include Acamprosate (Campral) and disulfiram (Antabuse and Antabus): Both medications are used together with behavior modification and counseling to assist people with alcohol use disorders who has recently quit drinking alcohol to stay in recovery.

MAT participants should:

Have been objectively diagnosed with an opioid use disorder
Follow safety precautions for the treatment, including follow-ups with primary care physician and treatment of chronic medical illnesses.
Have reviewed treatment options before agreeing to buprenorphine or naltrexone treatment
Multilingual Treatment Services
Outpatient level of care
Intensive Outpatient Program
Treatment Court Outpatient